Syria’s First Lady To Withdraw From Public Duty To Treat Leukaemia – Presidency
Joy ChukwuMay 21, 20241 Mins read912 
Asma al-Assad, Syria’s first lady, has been diagnosed with leukaemia, the Syrian presidency announced in a statement on Tuesday.
“First Lady Asma al-Assad has been diagnosed with acute myeloid leukaemia,” the statement read.
It revealed that she “will undergo a specialised treatment protocol” that requires social distancing to avoid infection, adding that she will “temporarily withdraw from all direct engagements as part of her treatment plan”.
Acute myeloid leukaemia is an aggressive cancer of the bone marrow and the blood.
Assad has previously been treated for breast cancer. In August 2019, she announced that she was “completely” free of the disease a year after her diagnosis.
About The Author
Related Articles
Boko Haram Attack Kills Over 20 Soldiers on Chad’s Lake Chad Island
At least 23 Chadian soldiers were killed and 26 others wounded in...
ECOWAS Confronts Ghana Over New Airport Taxes, Warns Of Regional Aviation Damage
A sharp dispute has broken out between the Economic Community of West...
Mali’s Leader Takes Defence Role After Minister’s Killing
Mali’s military leader, General Assimi Goïta, has appointed himself as the country’s...
Kled’s “Pay for Your Camera Roll” App Promises Quick Cash, but May Be Normalising Mass Data Extraction Across the Global South, Raising Ethical Concerns
A rapidly expanding artificial intelligence startup, Kled, is facing mounting scrutiny after...